- Home
- JZXN vs ASBP Comparison
JZXN vs ASBP Comparison
Compare JZXN & ASBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JZXN
- ASBP
- Stock Information
- Founded
- JZXN 2019
- ASBP 2021
- Country
- JZXN China
- ASBP United States
- Employees
- JZXN N/A
- ASBP N/A
- Industry
- JZXN Retail-Auto Dealers and Gas Stations
- ASBP Biotechnology: Pharmaceutical Preparations
- Sector
- JZXN Consumer Discretionary
- ASBP Health Care
- Exchange
- JZXN Nasdaq
- ASBP Nasdaq
- Market Cap
- JZXN 21.8M
- ASBP 18.9M
- IPO Year
- JZXN 2021
- ASBP N/A
- Fundamental
- Price
- JZXN $0.27
- ASBP $0.35
- Analyst Decision
- JZXN
- ASBP
- Analyst Count
- JZXN 0
- ASBP 0
- Target Price
- JZXN N/A
- ASBP N/A
- AVG Volume (30 Days)
- JZXN 10.2M
- ASBP 2.6M
- Earning Date
- JZXN 03-05-2026
- ASBP 11-24-2025
- Dividend Yield
- JZXN N/A
- ASBP N/A
- EPS Growth
- JZXN N/A
- ASBP N/A
- EPS
- JZXN N/A
- ASBP N/A
- Revenue
- JZXN $97,465.00
- ASBP N/A
- Revenue This Year
- JZXN N/A
- ASBP N/A
- Revenue Next Year
- JZXN N/A
- ASBP N/A
- P/E Ratio
- JZXN N/A
- ASBP N/A
- Revenue Growth
- JZXN N/A
- ASBP N/A
- 52 Week Low
- JZXN $0.25
- ASBP $0.20
- 52 Week High
- JZXN $7.82
- ASBP $15.80
- Technical
- Relative Strength Index (RSI)
- JZXN 34.41
- ASBP 47.16
- Support Level
- JZXN $0.27
- ASBP $0.35
- Resistance Level
- JZXN $0.39
- ASBP $0.47
- Average True Range (ATR)
- JZXN 0.05
- ASBP 0.06
- MACD
- JZXN 0.02
- ASBP 0.00
- Stochastic Oscillator
- JZXN 8.67
- ASBP 35.53
About JZXN Jiuzi Holdings Inc.
Jiuzi Holdings Inc operates as a franchise under the brand name Jiuzi. It sells new energy vehicles in third-fourth tier cities in China. The firm also sells plug-in electric vehicles on demand from vehicle buyers. Its operating segments are propretaey product; and resale of sourced Equipment and accessories from third party products. The company generates a majority of its revenue from the propretaey product segment. Geographically, the firm operates in China.
About ASBP Aspire Biopharma Holdings Inc. Common Stock
Aspire Biopharma Holdings Inc developing next-generation absorption of medicine that will have an impact on the opioid crisis. The group engaged in the business of developing and marketing disruptive technology for novel delivery mechanisms for do-no-harm drugs. Its nanotechnology drug formulation directly targets pain and inflammation bypassing the gastrointestinal tracts.